Big Molecule Watch Editor Nick Mitrokostas to Speak at Biosimilars in the Antitrust Spotlight: Patent Litigation and Settlement Webinar

Tomorrow, October 4th, Goodwin’s Nick Mitrokostas will participate as a panelist on the Biosimilars in the Antitrust Spotlight: Patent Litigation and Settlement webinar, discussing the likely shape of settlements in patent litigation between innovator biologic companies and biosimilar aspirants, the future of non-cash forms of compensation and whether “at-risk” entry is more or less likely than for traditional generic drugs.

Download PDF